Combat Counterfeit Medications: SwissRx Coin introduces a blockchain-based traceability system that tracks and verifies the ...
Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Sleeping sickness is no longer a health threat in Guinea, which may be a tipping point in the continent’s efforts to beat the ...
The medication is provided to patients who have had surgery or have been on bed rest and patients who are acutely ill and at high risk of blood clots in the veins. The court heard how had ...
The "Pharmaceutical R&D Outsourcing Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Pharmaceutical R&D Outsourcing Market was valued at USD 84.01 ...
Ms Badolé suffers from loiasis, a chronic filarial disease caused by the Loa loa parasite, also known as the African eye worm, which can cause a range of uncomfortable symptoms including intense ...
Trump's Administration Aims for 'Greater Transparency' in Drug Price Negotiations (Reuters) - The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price ...
To cope with dental pain, patients often are advised to take painkillers. However, many individuals in dental pain accidentally overdose on these drugs, which may lead to more serious health problems.
Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...
A major new analysis involving more than 130million people has revealed that five types of commonly taken medications could raise the risk of dementia. Antipsychotics, some medications for high ...
Speaking at a panel in Davos on Tuesday, Hudson said Sanofi uses AI to recommend whether drugs should "pass through a tollgate," or essentially get approval to move to the next phase of development.